Atlantic American AI Stock Analysis
Want to see AAME full AI Analyst Report?
Atlantic American (AAME) AI Stock Analysis
Atlantic American
(NASDAQ:AAME)
The score is anchored by improved financial performance (profitability and cash flow rebound with a cleaner balance sheet) and supportive valuation (low P/E with dividend). These positives are tempered by weak technical momentum and elevated corporate-risk signals from Nasdaq delisting/compliance issues related to late filings.
Atlantic American (AAME) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $25.70M
- Dividend Yield
- ―
- Average Volume (3M)
- 861.61K
- Price to Earnings (P/E)
- 5.1
- Beta (1Y)
- 0.90
- Revenue Growth
- 11.80%
- EPS Growth
- ―
- Country
- US
- Employees
- 163
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Insurance - Life
Atlantic American Business Overview & Revenue Model
Company Description
Atlantic American Corporation (AAME) is an insurance holding company that, through its subsidiaries, delivers a diverse range of life, health, and property & casualty insurance offerings throughout the United States. Its operations are segmented into...
Atlantic American Financial Statement Overview
Summary
Financials show a meaningful 2025 rebound: revenue growth improved, the company returned to profitability, operating/free cash flow stepped up sharply, and the balance sheet appears stronger with no reported debt. Offsetting this is a multi-year pattern of volatile profitability and cash flow (especially 2021–2024), which reduces confidence in durability.
Income Statement
58NeutralBalance Sheet
74PositiveCash Flow
82Very Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 210.44M | 210.44M | 188.23M | 186.79M | 187.85M | 199.55M |
| Gross Profit | 53.92M | 77.77M | 14.37M | 18.17M | 17.68M | 20.36M |
| EBITDA | 11.24M | 30.10M | -1.48M | 3.36M | 4.94M | 7.69M |
| Net Income | 6.02M | 6.02M | -4.27M | -171.00K | 1.52M | 4.28M |
Balance Sheet | ||||||
| Total Assets | 433.94M | 433.94M | 393.43M | 381.26M | 367.06M | 402.29M |
| Cash, Cash Equivalents and Short-Term Investments | 300.14M | 43.64M | 35.57M | 65.64M | 237.59M | 285.74M |
| Total Debt | 38.76M | 0 | 37.76M | 36.76M | 35.75M | 33.74M |
| Total Liabilities | 313.15M | 313.15M | 293.81M | 273.99M | 264.87M | 261.00M |
| Stockholders Equity | 120.79M | 120.79M | 99.61M | 107.28M | 102.19M | 141.29M |
Cash Flow | ||||||
| Free Cash Flow | 32.41M | 32.41M | 4.58M | 2.54M | 6.33M | 981.00K |
| Operating Cash Flow | 32.87M | 32.87M | 4.80M | 2.62M | 6.45M | 1.09M |
| Investing Cash Flow | -25.00M | -25.00M | 2.28M | -3.37M | -3.43M | 5.30M |
| Financing Cash Flow | 189.00K | 189.00K | 186.00K | 181.00K | 1.08M | -954.00K |
Atlantic American Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AAME, the sentiment is Positive. The current price of 1.26 is above the 20-day moving average (MA) of 1.24, above the 50-day MA of 1.26, and below the 200-day MA of 1.90, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 52.56 is Neutral, neither overbought nor oversold. The STOCH value of 74.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AAME.
Atlantic American Peers Comparison
Overall Rating
AAME62Neutral
CIA53Neutral
Financial Indicators
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AAME | Atlantic American | 1.26 | -1.40 | -52.63% | |
| CIA | Citizens Inc | 3.26 | -2.36 | -41.99% |
Atlantic American Corporate Events
Atlantic American Shareholders Approve Directors and Auditor Appointment
NeutralAt its annual meeting on Tuesday, November 10, 2026, Atlantic American shareholders voted on six directors; each received between 16,290,853 and 16,385,718 votes for, with votes withheld ranging from 587,542 to 682,407 and no broker non-votes. Shareh...
Atlantic American Faces Nasdaq Delisting, Plans Appeal
NegativeAtlantic American Corporation disclosed that on October 16, 2026, Nasdaq staff issued a determination to begin delisting its common stock because the company failed to timely file its 2025 annual report and its quarterly reports for March 31 and June...
Atlantic American Extends Credit Agreement, Tightens Rating Terms
NeutralOn October 9, 2026, Atlantic American Corporation executed a fourth amendment to its revolving credit agreement with Truist Bank, pushing back deadlines for delivering its audited 2025 financial statements and 2026 interim quarterly results, along wi...
Atlantic American Faces Nasdaq Compliance Deadline on Filings
NegativeAtlantic American Corporation, an insurance holding company focused on specialty life, health, and property and casualty lines through multiple subsidiaries, maintains its listing on The Nasdaq Global Market despite recent compliance challenges. The...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 31, 2026
